In 2019, only 14 European and Central Asian countries provided reimbursed HIV pre-exposure prophylaxis (PrEP). Using EMIS-2017 data, we present the difference between self-reported use and expressed need for PrEP in individual countries and the European Union (EU). We estimate that 500,000 men who have sex with men in the EU cannot access PrEP, although they would be very likely to use it. PrEP's potential to eliminate HIV is currently unrealised by national healthcare systems.
Keywords: Europe and Central Asia; European Union; Human Immunodeficiency Virus (HIV); Men who have sex with Men (MSM); Pre-exposure prophylaxis (PrEP).